What is Ruby Bio worth?
$24.0Mlast known valuation
Ruby Bio last raised $8.0M in its Early Stage VC (May 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Ruby Bio
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2025 | Early Stage VC | $8.0M | ▮ | ▮ |
| Sep 2022 | Early Stage VC | $5.1M | ▮ | ▮ |
How Ruby Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ruby Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Ruby Bio worth?
- Ruby Bio's last known valuation is $24.0M.
- How much has Ruby Bio raised?
- Ruby Bio has raised $8.0M in total funding across 2 recorded rounds.
- When did Ruby Bio last raise?
- Ruby Bio last raised in May 2025 (Early Stage VC), raising $8.0M.